Triple
T2138526
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Roche |
E46707
|
entity |
| Predicate | hasDivision |
P35
|
FINISHED |
| Object |
Diagnostics Division
The Diagnostics Division is a major business unit of Roche that develops and supplies diagnostic systems, tests, and related technologies for healthcare and clinical laboratories worldwide.
|
E238183
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Diagnostics Division | Statement: [Roche, hasDivision, Diagnostics Division]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Diagnostics Division Context triple: [Roche, hasDivision, Diagnostics Division]
-
A.
Division of Cancer Treatment and Diagnosis
The Division of Cancer Treatment and Diagnosis is a branch of the National Cancer Institute that supports the development, evaluation, and clinical testing of new cancer therapies and diagnostic tools.
-
B.
Inspection and Evaluation Division
The Inspection and Evaluation Division is a unit within the United Nations system responsible for assessing the efficiency, effectiveness, and impact of UN programmes and activities to support oversight and accountability.
-
C.
Structural Studies Division
The Structural Studies Division is a research unit at the MRC Laboratory of Molecular Biology focused on elucidating the three-dimensional structures and mechanisms of biological macromolecules.
-
D.
Division of Health Assessment and Consultation
The Division of Health Assessment and Consultation is a branch of the U.S. Agency for Toxic Substances and Disease Registry that evaluates environmental health risks and provides guidance to protect communities from hazardous exposures.
-
E.
Sciences Division
The Sciences Division is a primary branch of the Israel Academy of Sciences and Humanities responsible for advancing and overseeing scientific research and scholarship.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Diagnostics Division Triple: [Roche, hasDivision, Diagnostics Division]
Generated description
The Diagnostics Division is a major business unit of Roche that develops and supplies diagnostic systems, tests, and related technologies for healthcare and clinical laboratories worldwide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Diagnostics Division Target entity description: The Diagnostics Division is a major business unit of Roche that develops and supplies diagnostic systems, tests, and related technologies for healthcare and clinical laboratories worldwide.
-
A.
Division of Cancer Treatment and Diagnosis
The Division of Cancer Treatment and Diagnosis is a branch of the National Cancer Institute that supports the development, evaluation, and clinical testing of new cancer therapies and diagnostic tools.
-
B.
Inspection and Evaluation Division
The Inspection and Evaluation Division is a unit within the United Nations system responsible for assessing the efficiency, effectiveness, and impact of UN programmes and activities to support oversight and accountability.
-
C.
Structural Studies Division
The Structural Studies Division is a research unit at the MRC Laboratory of Molecular Biology focused on elucidating the three-dimensional structures and mechanisms of biological macromolecules.
-
D.
Division of Health Assessment and Consultation
The Division of Health Assessment and Consultation is a branch of the U.S. Agency for Toxic Substances and Disease Registry that evaluates environmental health risks and provides guidance to protect communities from hazardous exposures.
-
E.
Sciences Division
The Sciences Division is a primary branch of the Israel Academy of Sciences and Humanities responsible for advancing and overseeing scientific research and scholarship.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a88a174ab48190a5db20c132e5dccf |
completed | March 4, 2026, 7:37 p.m. |
| NER | Named-entity recognition | batch_69abbe012aa481909ffa0a50e58efabb |
completed | March 7, 2026, 5:56 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ae51b1290c8190a08850b428c99a6c |
completed | March 9, 2026, 4:50 a.m. |
| NEDg | Description generation | batch_69ae55923b748190bf7a2df3ae94edc8 |
completed | March 9, 2026, 5:07 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69ae55fdc32c8190b6ecdc9b23d64cc5 |
completed | March 9, 2026, 5:09 a.m. |
Created at: March 4, 2026, 7:44 p.m.